Bombay Alkalodis Private Limited
About Bombay Alkalodis Private Limited
Data last updated:
Bombay Alkalodis Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 August 1965 and has been in existence for over 61 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH1965PTC013300. Its GSTIN is 27AAACB6887H1ZC (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹3.5 Lakh. It was formerly known as Bombay Alkaloids Private Limited. It is led by directors including Silpa Narendra Shah and Ashwin Mangaldas Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 194 Samuel Street, Mumbai, Maharashtra, India – 400009.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.65 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.52 Cr (net margin 92.1%) and EBITDA of ₹1.52 Cr (EBITDA margin 92.1%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 18% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Bombay Alkalodis Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address194 Samuel Street, Mumbai, Maharashtra, India – 400009
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bombay Alkalodis Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bombay Alkalodis is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
Financials of Bombay Alkalodis Private Limited
FY 2025 filings availableBombay Alkalodis Private Limited reported revenue of ₹1.65 Cr (up 244% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 244% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.52 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 92.1% | ||||
| Net Profit Margin | 92.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bombay Alkalodis Private Limited, buy the company report.
Board of directors of Bombay Alkalodis Private Limited
Bombay Alkalodis has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Silpa Narendra Shah | Director | 22 Mar 2024 | 2 Years 7 Months | Current |
| Ashwin Mangaldas Shah | Director | 01 Apr 1991 | 35 Years 7 Months | Current |
| Dharmesh Kantilal Shah Also directs: Multilink Systems Private Limited | Director | 30 Nov 2015 | 10 Years 11 Months | Current |
Auditor
Bombay Alkalodis Private Limited is audited by SHAH DEDHIA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHAH DEDHIA & ASSOCIATES | FY 2019 | 102605W |
Shareholding
The shareholding of Bombay Alkalodis Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Bombay Alkalodis Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bombay Alkalodis Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bombay Alkalodis Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bombay Alkalodis has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACB6887H1ZC | Maharashtra | Active | 01 Jul 2017 |
| 24AAACB6887H1ZI | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bombay Alkalodis Private Limited, buy the company report.
Recent activity
Bombay Alkalodis Private Limited has 6 board changes on record since 1991: 3 appointments and 3 cessations. The latest: Silpa Narendra Shah ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Bombay Alkalodis is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 August 1965 (61+ years old) and is registered under CIN U24100MH1965PTC013300.
Bombay Alkalodis has 3 current directors:
- Silpa Narendra Shah - Director
- Ashwin Mangaldas Shah - Director
- Dharmesh Kantilal Shah - Director
The latest financial statements of Bombay Alkalodis on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bombay Alkalodis is 27AAACB6887H1ZC, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAACB6887H1ZI (Gujarat).
The CIN (Corporate Identification Number) of Bombay Alkalodis is U24100MH1965PTC013300. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bombay Alkalodis was incorporated on 23 August 1965, making it 61+ years old. It is registered with the Registrar of Companies, Mumbai.
Silpa Narendra Shah ceased to be Additional Director on 29 Sep 2024. Silpa Narendra Shah was appointed as Director on 22 Mar 2024. Narendra Kantilal Shah ceased to be Director on 01 Feb 2024. Bombay Alkalodis has 6 board changes on record in total.
The registered office of Bombay Alkalodis is at 194 Samuel Street, Mumbai, Maharashtra, India – 400009.
Bombay Alkalodis operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Bombay Alkalodis is compliant as of 22 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
